Tirzepatide works on two hormone pathways at once, both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide), rather than targeting GLP-1 alone. This dual-action mechanism is often discussed as a key difference between Tirzepatide and single-pathway GLP-1 medications like Semaglutide.
Tirzepatide is often considered by those who have plateaued on other weight management approaches, or who are specifically interested in a dual-pathway option.
Tirzepatide + B12 is available at three treatment phases, Initiation, Titration, and Maintenance, as your Nurse Practitioner gradually adjusts your dose over time.
This information is educational and general in nature. It is not medical advice and does not guarantee any specific outcome. A licensed prescriber will determine whether Tirzepatide is appropriate for you following a clinical evaluation.
Related
Experiencing nausea during treatment? Ondansetron ODT is available as a 9 add-on for current clients.
Get Started